Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Creo Medical ( (GB:CREO) ) just unveiled an announcement.
Creo Medical Group PLC announced that its total issued share capital is composed of 412,473,319 Ordinary Shares, each with one voting right. This update is significant for shareholders calculating their interests according to the FCA’s Disclosure and Transparency Rules. The announcement reinforces the company’s commitment to transparency and could influence shareholder engagement and regulatory compliance.
More about Creo Medical
Creo Medical is a medical device company that specializes in the development and commercialization of minimally invasive electrosurgical devices. The company focuses on enhancing surgical and endoscopic procedures through its advanced CROMA technology, powered by Kamaptive, which integrates multi-modal energy sources to adapt dynamically to patient tissue during medical procedures. This technology aims to improve patient outcomes by offering less invasive, safer, and more cost-efficient surgical solutions.
YTD Price Performance: -7.69%
Average Trading Volume: 868,704
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £74.25M
Find detailed analytics on CREO stock on TipRanks’ Stock Analysis page.
